Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > ACP-01 Midpoint Analysis
View:
Comment by Budaman on Aug 10, 2022 4:26pm
Try again troll. The article was from 2020. If the results were not great, why would Aspire fight tooth and nail not to return the results? By all means, if you can lower the SP so I can buy more, please do. Until then, I dare you to short the stock. In my opinion only. Thanks for trying -Buda.
Comment by FredZarfloon on Aug 11, 2022 4:07pm
What were the terms of the court settlement between HEM and Aspire?
Comment by WalterTheDawg on Aug 11, 2022 5:55pm
Undisclosed amount in a cash settlement for all rights and data. The assumption is that Aspire released that report on the midpoint in an attempt to disuade management from going after the rights. This theory assumes that they, in collusion with Accudata whose name is on the report, misrepresented the data which is kind of a big assumption. However what Aspire was going for in the Florida case was ...more  
Comment by FredZarfloon on Aug 12, 2022 5:09pm
Thanks for informative response. If Accudata and Aspire misrepresented the data, that would be fraud - no? But I see the court accepted Aspire's 'Motion to Dismiss' Count VII (fraud) in 03/21. Regardless, interesting story and GLTA. 
Comment by WalterTheDawg on Aug 12, 2022 5:44pm
Ya that would be fraud you would think and it has always made me second guess how this data will pan out. Then again, you wouldn't be able to charge them with fraud without having the data which Aspire refused to hand over until the deal was already done. In any case the complete data set has another 23 patients so hopefully if that report was true, the last patients could change the result ...more  
Comment by WalterTheDawg on Aug 12, 2022 5:52pm
Also if I were Aspire and knew I had put out misleading info for which i could be held liable I would definitely hold on to the evidence and have any settlement include a clause stating i can't be sued afterwards for any interpretation i previously made public. I mean they did a lot of shady sh1t so I wouldn't put it past them and they also said in that NR that they delivered a copy of ...more